Barclays lowered the firm’s price target on Cemex (CX) to $8 from $9 and keeps an Overweight rating on the shares. The company reported soft Q4 results with operating EBITDA coming in at $747M, well below Barclays’ estimate of $802M, the analyst tells investors in a research note. However, the firm believes most of the negative is priced into the shares.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.